A novel site on dual-specificity phosphatase MKP7/DUSP16 is required for catalysis and MAPK binding

Shanelle Shillingford1, Lei Zhang2, Yulia Surovtseva3

  • 1Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut, USA; Department of Chemistry, Yale University, New Haven, Connecticut, USA.

Insights

Mutation of tyrosine 271 in MAPK phosphatase 7 (MKP7) inhibits its catalytic activity, reducing dephosphorylation of substrates like p38 MAPK and JNK. This highlights Y271

Area of Science:

  • Molecular Biology
  • Enzymology
  • Cell Signaling

Background:

  • Mitogen-activated protein kinases (MAPKs) are crucial signaling molecules regulated by MAPK phosphatases (MKPs).
  • MKP5 regulation involves a novel allosteric site, suggesting diverse regulatory mechanisms within the MKP family.

Purpose of the Study:

  • To investigate the functional importance of an equivalent allosteric site in MKP7, a close relative of MKP5.
  • To determine if mutations in this site affect MKP7's catalytic activity and substrate interactions.

Main Methods:

  • Site-directed mutagenesis of tyrosine 271 (Y271) in MKP7.
  • Assessing MKP7 catalytic activity in vitro.
  • Overexpression of wild-type and mutant MKP7 in cells.
  • Analyzing substrate (p38 MAPK, JNK) dephosphorylation and cellular localization.

Main Results:

  • Mutation of Y271 significantly inhibited MKP7's catalytic activity.
  • MKP7 Y271 mutants failed to dephosphorylate p38 MAPK and JNK in cells.
  • Binding efficiency of MKP7 to MAPKs was reduced by the Y271 mutation.
  • Overexpression of Y271 mutants led to increased nuclear accumulation of p38 MAPK and JNK.

Conclusions:

  • Tyrosine 271 is critical for MKP7's dephosphorylation function, likely by mediating substrate binding prior to catalytic site engagement.
  • MKP7 allosteric site mutations potentiate MAPK signaling upon overexpression.
  • These findings support the generality of the MKP allosteric site and offer a basis for targeting MKP7 with small molecules.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.9K
Microtubule Associated Proteins (MAPs)01:42

Microtubule Associated Proteins (MAPs)

Microtubule function and architecture are regulated by an array of specialized proteins called microtubule-associated proteins or MAPs. These proteins are widespread across different organisms and have conserved protein motifs, like the multi-TOG domain for tubulin binding found in the CLASP family of MAPs. Some MAPs are lineage-specific based on their conserved domains. Their functions depend upon the cytoskeletal architecture and cell type they are located within. In-plant cells, a specific...
4.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.8K
Microtubule Instability02:17

Microtubule Instability

Microtubules are hollow cylindrical filaments having a diameter of approximately 25 nm and a length that varies from 200 nm to 25 μm. GTP-bound tubulin subunits form αβ-heterodimers for microtubule assembly. These core building blocks interact longitudinally, polymerizing into protofilaments. The protofilaments then interact with one another through lateral bonding forces to form stable cylindrical microtubules. These cylindrical filaments are dynamic as they undergo repeated...
5.2K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.7K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K